Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 7, 1996, Pages 614-620

  Sattar, Naveed ^a   Gaw, Allan ^a   Packard, Chris J ^a   Greer, Ian A ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID METABOLISM; FEMALE; FETUS; FETUS DEVELOPMENT; HELLP SYNDROME; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN METABOLISM; OXIDATION; PREECLAMPSIA; PRIORITY JOURNAL; REVIEW; REYE SYNDROME;

ANIMALS; CYTOKINES; FATTY ACIDS; FEMALE; HORSE DISEASES; HORSES; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID PEROXIDES; LIPOPROTEINS; OBESITY; OXIDATION-REDUCTION; PRE-ECLAMPSIA; PREGNANCY;

EID: 0030001168     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09827.x     Document Type: Review

References (57)

1. Roberts JM, Redman CWG. Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 1993; 341: 1447–1451.
2. Rodgers GM, Taylor RN, Roberts JM. Pre-eclampsia is associated with a serum factor cytotoxic to human endothelial cells. Am J Obstet Gynecol 1988; 159: 908–914.
3. Minakami H, Oka N, Sato T et al. Pre-eclampsia: A microvesicular fat disease of the liver Am J Obstet Gynecol 1988; 159: 1043–1047.
4. Watson TDG, Burns L, Packard CJ et al. Plasma lipids, lipoproteins and post-heparin lipases in ponies with hyperlipaemia. Equine Vet J 1992; 24: 341–346.
5. Dixon JL, Ginsberg HN. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: Information obtained from cultured liver cells. J Lipid Res 1993; 34: 167–179.
6. Chaves-Carbello E, Carter GA, Wiebe DA. Triglyceride and cholesterol concentrations in whole serum and in serum lipoproteins and Reye syndrome. Paediatrics 1979; 64: 592–597.
7. Heubi JE, Partin JC, Partin JS, Schubert WK. Reye's syndrome current concepts. Hepatology 1987; 7: 155–164.
8. Deschamps D, Fisch C, Fromenty B et al. Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids: Possible role in the development of Reye's syndrome. J Pharmacol Exp Ther 1991; 259: 894–904.
9. Grimbert S, Fromenty B, Fisch C et al. Decreased mitochondrial oxidation of fatty acids in pregnant mice: Possible relevance to development of acute fatty liver of pregnancy. Hepatology 1993; 17: 628–637.
10. Martin-Hidalgo A, Hom C, Belfrage M, Schotz MC, Herrera E. Lipoprotein-lipase and hormone-sensitive lipase activity and mRNA in rat adipose tissue during pregnancy. Am J Physiol 1994; 266: 930–935.
11. Silliman K, Shore V, Forte T. Hypertriglyceridaemia during late pregnancy is associated with the formation of small, dense low-density lipoprotein and the presence of large buoyant high-density lipoproteins. Metabolism 1994; 43: 1035–1041.
12. I4C] oleate by perfused livers and hepatocytes from female rates. Biochem J 1979; 180: 265–271.
13. Wasfi I, Weinstein I, Heimberg M. Increased formation of triglyceride from oleate in perfused livers from pregnant rats. Endocrinology 1980; 107: 584–590.
14. O'Sullivan AJ, Hoffman DM, Ho KKY. Estrogen, lipid oxidation and body fat. N Engl J Med 1995; 333: 669–670.
15. Lorentzen B, Endersen MJ, Clausen T, Henriksen T. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop pre-eclampsia. Hypertens Pregnancy 1994; 13: 103–109.
16. Endresen MJ, Lorentzen B, Henriksen T. Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with pre-eclampsia leads to triglyceride accumulation in cultured endothelial cells. Am J Obstet Gynecol 1992; 167: 440–447.
17. Lorentzen B, Endresen MJ, Hovig T, Haug E, Henriksen T. Sera from pre-eclamptic women increase the content of triglycerides and reduce the release of prostacyclin in cultured endothelial cells. Thromb Res 1991; 63: 363–372.
18. Potter JM, Nestel PJ. The hyperlipidaemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 1979; 133: 165–170.
19. Kaaja R, Tikkanen M, Vinikka L, Ylikorkala O. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol 1995; 85: 353–356.
20. Treem WR, Rinaldo P, Hale DE et al. Acute fatty liver of pregnancy and long chain 3-hydroxacyl-coenzyme A dehydrogenase deficiency. Hepatology 1994; 19: 339–345.
21. Wilcken B, Leung KC, Hammond J, Kamath R, Leonard JV. Pregnancy and fetal long-chain 3–hydroxyacylcoenzyme A dehydrogenase deficiency. Lancer 1993; 341: 407–408.
22. Visser W, Beckmann I, Bremer HA, Lim HL, Wallenburg HCS. Bioactive tumour necrosis factor u in pre-eclamptic patients with and without the HELLP syndrome. Br J Obstet Gynaecol 1994; 101: 1081–1082.
23. Vince GS, Starkey PM, Austgule R, Kwiatkowski D, Redman CWG. Interleukin-6, tumour necrosis factor and soluble tunour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995; 102: 20–25.
24. Greer IA, Lyall F, Parvera T, Boswell F, Macacra LM. Increased concentrations of cytokines IL-6 and IL-1 receptor antagonist in plasma of women with pre-eclampsia: A mechanism for endothelial dysfunction. Obsret Gynecol 1995; 84: 937–940.
25. Chajek-Schaul T, Friedman G, Stein O et al. Mechanism of the hypertriglyceridaemia induced by tumor necrosis factor administration to rats. Biochim Biophys Acta 1989; 1001: 316–324.
26. Feingold KR, Soued M, Adi S et al. Effects of interleukin-I on lipid metabolism in the rat: Similarities to and differences from tumor necrosis factor. Arterioscler Thromb 1991; 11: 445–450.
27. Greenberg AS, Nordan SP, Mclntosh J et al. Interleukin-6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3–LI adipocytes. Mol Cell Biol 1988; 8: 2394–2401.
28. Memon RA, Feingold KR, Moser AH et al. Differential effects of interleukin-I and tumor necrosis factor on ketogenesis. Am J Physiol 1992; 263: E301–E309.
29. Saxena U, Witte LD, Goldberg IJ. Tumor necrosis factor induced release of endothelial cell lipoprotein lipase. Arteriosclerosis 1990; 10: 470–476.
30. Maseki M, Nishigaki I, Hagihara M, Tomoda Y, Yagi K. Lipid peroxide levels and lipid content of serum lipoprotein fractions of pregnant subjects with or without pre-eclampsia. Clin Chim Acta 1981; 115: 151–161.
31. Uotila JT, Tuimala RJ, Aarnio TM, Pykko KA, Ahotupa MD. Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy. Er J Obstet Gynaecol 1993; 100: 270–276.
32. Saibara T, Himeno H, Ueda H et al. Acute hepatic failure with swollen mitochondria and microvesicular fatty degeneration of hepatocytes triggered by a free radical initiator. Lab Invest 1994; 70: 517–524.
33. Stark JM. Pre-eclampsia and cytokine induced oxidative stress. Er J Obsret Gynaecol 1993; 100: 105–109.
34. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for pre-eclampsia. JAMA 1991; 266: 237–241.
35. Sibai BM, Gordon T, Thom E et al. Risk factors for preeclampsia in healthy nulliparous women: A prospective multicenter study. Am J Obsret Gynecol 1995; 112: 642–648.
36. Kissebah AH, Peiris AN. Biology of body fat distribution: Relationship to non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 1989; 5: 83–109.
37. Mauriege P, Despres JP, Prud'homme D et al. Regional variation in adipose tissue lipolysis in lean and obese man. J Lipid Res 1991; 32: 1625–1633.
38. Despres JP. Obesity and lipid metabolism: Relevance of body fat distribution. Curr Opin Lipidol 1991; 2: 5–15.
39. Björntorp P. Fatty acids, hyperinsulinemia, and insulin resistance: Which comes first Curr Opin Lipidol 1994; 5: 166–174.
40. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989; 83: 1168–1173.
41. Stewart DJ, Monge JC. Hyperlipidaemia and endothelial dysfunction. Curr Opin Lipidol 1993; 4: 319–324.
42. Gianturco SH, Eskin SG, Navarro LT et al. Abnormal effects of hypertriacylglycerolemic very low density lipoproteins on 3-hydroxy-3-methylglutaryl-CoA reductase activity and viability of cultured bovine aortic endothelial cells. Biochim Biophys Acta 1980; 618: 143–152.
43. Spiedel MT, Booyse FM, Abrams A, Moore MA, Chung BH. Lipolysed hypertriglyceridemic serum and triglyceride-rich lipoprotein cause lipid accumulation in and are cytotoxic to cultured human endothelial cells. High density lipoprotein inhibit this cytotoxicity. Thromb Res 1990; 58: 251–264.
44. McNamara JR, Jenner JL, Zengling L, Wilson PNF, Schaefer EJ. Change in LDL particle size in associated with change in plasma triglyceride concentration. Arterioscler Thromb 1992; 12: 1284–1290.
45. DeGraaf J, Hak-Lemmers HL, Hectors MPC et al. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991; 11: 298–306.
46. Kume N, Cybulsky MI, Gimbrone MA. Lysophosphatidyl-choline, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992; 90: 1138–1144.
47. Lyall F, Greer IA, Boswell F et al. The cell adhesion molecule VECAM-1 is selectively elevated in pre-eclampsia: Does this indicate the mechanism of neutrophil activation Er J Obstet Gynaecol 1994; 101: 485–487.
48. Lehr HA, Krombach F, Munzing S et al. In vitro effects of oxidised low density lipoprotein on CD1 1b/CD18 and L-selectin presentation on neutrophils and monocytes with relevance for the in vivo situation. Am J Pathol 1995; 146: 218–227.
49. Thomas CE, Jackson RL, Ohlweiler DF, Ku G. Multiple oxidation products in LDL induce IL-lP release from human blood mononuclear cells. J Lipid Res 1994; 35: 417–427.
50. Mackness MI, Durrington PN. HDL, its enzyme and its potential to influence lipid peroxidation. Atherosclerosis 1995; 115: 243–253.
51. Greer IA. Haemostasis and thrombosis in pregnancy. In: Bloom AL, Forbes, C, editors. Haemostasis and Thrombosis. London : Butterworths, 1994; 987–1015.
52. Walli AK, Grone E, Miller B et al. Role of lipoproteins in progressive renal disease. Am J Hypertens 1993; 6: 358S–366s.
53. Garber LW, Spargo BH, Lindheimer MD. Renal pathology in pre-eclampsia. Ballières Clin Obstet Gynaecol 1994; 8: 448–467.
54. Herrera E, Lasuncion MA, Gomez-Coronado D et al. Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of the circulating triglycerides in pregnancy. Am J Obsret Gynecol 1988; 158: 1575–1583.
55. Bonet B, Brunzell JD, Gown AM, Knopp RH. Metabolism of very low density lipoprotein triglyceride by human placental cells: The role of lipoprotein lipase. Metabolism 1992; 41: 596–603.
56. Gafvels ME, Paavola LG, Boyd CO et al. Cloning of a complementary deoxyribonucleic acid encoding the murine homolog of the very low density lipoprotein/apolipoprotein-E receptor: Expression pattern and assignment of the gene to mouse chromosome 19. Endocrinology 1994; 135: 387–394.
57. Biale Y. Lipolytic activity in the placentas of chronically deprived fetuses. Acta Obsret Gynecol 1985; 64: 111–114.